See the first dog ever treated with insulin—a peptide

Leonard Thompson was the first human to receive an insulin injection for diabetes

In January 1922, the 14-year-old was the first person to receive an insulin injection to treat diabetes, just months after insulin was isolated in dogs and used to treat their induced diabetes. Thompson had an allergic response to an apparent impurity in the injection, but his second dose, 12 days later, was a success.

Peptide research dates back to the late 1800s

Peptide science dates back to the late 1800s with some early peptide synthesis work, but peptides took off in the medical sphere after surgeon Frederick Banting and his colleague's isolation of insulin from dog pancreases in 1921.

Early peptide research focused on isolating the substances from animal tissue

In the first half of the 20th century, peptides including insulin and adrenocorticotropic hormone were isolated from animals to provide life-saving medicines. ACTH was isolated from the pituitary glands of cows and pigs and insulin was isolated from the pancreas of dogs and cows.

The discovery of insulin led to a controversial Nobel Prize in 1923

For centuries, Type 1 diabetes was fatal. The 1920s "discovery" of insulin netted two of its creators—Frederick Banting and his boss, John Macleod—a Nobel prize. Separately, the German doctor Georg Zuelzer synthesized an effective version of the life-saving drug years earlier but was interrupted by World War I.

An overview of 200 years of diabetes treatment

Diabetes treatment became truly effective after the advent of insulin injections in the early 1900s. Diabetes is becoming increasingly common. Current trends estimate one in three Americans will have diabetes by 2050. This overview explores two centuries of diabetes treatment—starting in 1812—and outline potential challenges to treatment and prevention.

Diabetes drug GLP-1 is a peptide (that's what the 'P' is for).

When was the first blood transfusion?

In the 1600s, an English doctor transferred the blood from one dog to another via quills. The procedure ended when one of the dogs died. This article details the early days of blood transfusions, which turned toward humans shortly after the 1666 dog experiment and involved putting the blood of a sheep into a human recipient (who reportedly survived the encounter).

Understanding insulin

Scientists Daniel and Kelly talk with researcher Dr. Katrine Whiteson about diabetes, the history of insulin production, and Dr. Lydia Villa-Komaroff—an essential member of the team who discovered that bacteria could be induced to produce insulin. Listen to discover interesting facts about the life-saving medicine and how it works in the human body.

Dogs' disease-sniffing skills were first identified in 1989

This capability, reported in the medical journal The Lancet, was discovered when a dog reportedly detected cancer in its handler. The dog repeatedly focused on a spot on the owner's leg where a malignant melanoma lesion was later found, helping lead to an early diagnosis.

Peptides like GLP-1 account for 31 of 370 new drugs approved by the US FDA between 2016 and 2023.

Explore different pig-to-human xenotransplantation possibilities, including using pig pancreatic cells for treating diabetes.

GLP-1 drugs, first used to manage diabetes, were derived from Gila monster saliva.

Without the option of modern blood transfusions, some doctors in the mid-1800s tried to help save cholera patients by injecting them with cow's milk, hoping it would boost their nutrition and hydration.

Read a deep dive on the 'all-purpose healing' peptide BPC-157.

Type 1 diabetes, affecting about 5%-10% of people with diabetes, is an autoimmune disorder inhibiting insulin production.

GLP-1s are netting interest for treating autoimmune diseases, but are considered experimental

Already used to treat type 2 diabetes, the novel medications are showing some early promise in experimental studies at reducing inflammation and treating autoimmune conditions including rheumatoid arthritis and inflammatory bowel conditions. But researchers caution that side effects are still under investigation—rarely the medication has caused lupus, an autoimmune disease.

Diabetes 101: Insulin deficiency leads to high glucose levels in the blood

Glucose, the brain's preferred energy source, enters the bloodstream when the body breaks down consumed carbohydrates. To manage this increase in readily available energy, the body releases the hormone insulin, which allows glucose to enter and fuel our cells. Without insulin, glucose remains in the blood, causing health issues.

Two dogs were able to detect prostate cancer in 98% of patients in one study

In this small study published in 2015, two highly trained German Shepherd dogs sniffed hundreds of urine samples and were able to accurately detect prostate cancer—sniffing out certain volatile organic compounds—in almost every single case. One dog was correct 98% of the time and the other correctly identified patients 100% of the time. (Some users may encounter a paywall.)

Xenotransplants are an experimental last resort for the terminally ill when they cannot or will not receive a human organ.

Efforts to create disease-sniffing capabilities for phones still can't match dogs

In this video, a scientist explains why dogs remain leaders in olfactory capabilities, outpacing technology. Scientists have attempted to create artificial "e-noses" for phones to detect early signs of disease, but so far they have not been successful.

In 1933, the influenza virus was first identified through 'ferret flu' experiments, which proved that the disease was viral—not bacterial.

Recombinant DNA technology turns microorganisms into protein factories

Genes for molecules such as insulin can be inserted into loops of bacterial DNA called plasmids and reinserted into bacteria. Once placed in fermentation tanks, these bacteria use the gene to produce these molecules, which are then harvested and purified for eventual use.

Insulin is a hormone that controls blood sugar by helping absorb it into cells

Blood sugar levels increase after a meal when the body starts turning food into usable fuel—sugars, proteins, and more—which are absorbed into the bloodstream through the intestines. Blood sugar levels rise, releasing insulin, and letting sugar in the blood be absorbed into hungry cells, thereby dropping blood sugar levels.

Scientists using gene therapy recently managed to regenerate retinal cells in the lab—a breakthrough for mammals that could potentially lead to future treatments for human retinal diseases.

Cross-species transplantation has been attempted in medicine for more than 300 years.

When people stopped using GLP-1, they regained two-thirds of the weight back.

A scientist successfully treated her own breast cancer by injecting the tumor with lab-grown viruses.

Diabetes is a hormonal disorder that occurs when the pancreas does not produce enough of a hormone that regulates blood glucose, called insulin, or when the body cannot effectively use the insulin it produces.

Is it possible to cure diabetes?

Treatments for diabetes depend on the type of condition a patient has. Gestational diabetes typically goes away after birth, and those with Type 2 diabetes may be able to reverse their condition through diet, exercise, and blood sugar management. Type 1 diabetes has no cure, but can be successfully managed.

Diabetes is a chronic disease linked to insulin production and high blood sugar

Diabetes is a chronic, progressive disease caused by a lack of, or problems processing, the hormone insulin, leading to persistently high blood sugar. Around 90 to 95% of cases are Type 2 (chronic and caused by factors like diet and environment). The remainder are Type 1 diabetes (an autoimmune disorder).

The Dog Aging Project uses information from over 50,000 dogs to explore longevity

The study gathers health, lifestyle, and genetic data to understand what helps dogs live longer, healthier lives. Findings could also provide human health insights due to our shared surroundings and biology.

Light therapy was widely used as a medical treatment for various maladies in the early 1900s before it was replaced by antibiotics.

The first newborn screen for diseases was developed in 1961.

How Seabiscuit's DNA made him a winner

Seabiscuit's sudden success in the sport has been framed as a classic against-the-odds sports story. One Binghamton University molecular physiologist wanted to go a bit deeper, though, to see how much genetics played a role in the horse's legendary career. Using the horse's silvered hooves, his research team discovered that Seabiscuit's genotype was typically associated with late bloomers, a finding confirmed by the horse's track record.

Peptides like BPC-157 are marketed based largely on animal studies, not human research

BPC-157, which purportedly helps with tissue repair and muscle growth, can cause concerning side effects, including pain and swelling. TB-500, another experimental peptide, is marketed for wound healing, but it hasn't undergone any clinical human trials, and high levels of this peptide have been linked to tumor growth. (Some users may encounter a paywall.)

The World Anti-Doping Agency has banned many peptides

The global body has an entire section dedicated to banned peptide hormones, including ones that may stimulate growth hormones and testosterone. BPC-157 was added to the list in 2022.

GLP-1 drugs are under investigation for treating Alzheimer's, Parkinson's, and drug addiction

Researchers are investigating GLP-1 applications for a variety of chronic conditions. One area of interest stems from how study participants using GLP-1 for diabetes and obesity reported describing less longing for wine and cigarettes while taking the medication—intriguing researchers about using the drugs for addiction applications. The drug, they theorize, could bind to receptors that mediate desire. (Some users may experience a paywall.)

See which GLP-1 drugs are currently approved (along with their cost)

Around 75% of prescriptions for GLP-1 drugs are used to treat diabetes, while the remainder is used for weight loss. This overview from GoodRX includes a list and overview of currently available options along with prices for each.

China is producing many peptides or peptide components sold in the US.

A first-of-its-kind clinical trial taps livers from gene-edited pigs to clean blood

The experimental dialysis-like treatment from United Therapeutics, eGenesis, and OrganOx, is designed to help people with liver failure. The therapy, which involves attaching the modified pig liver externally, filters a patient’s blood so their own livers can temporarily rest and perhaps heal.

How Gleevec transformed leukemia treatment and cancer research

An outline of the discovery of imatinib (Gleevec), a ground-breaking drug that transformed the treatment of chronic myelogenous leukemia and sparked the beginning of precision medicine.

‘Hope for Healing’: The first-ever use of an in utero stem cell treatment

In 2023, researchers at UC Davis performed the first-ever fetal stem cell transplant, attempting to cure a case of spinal bifida prior to childbirth using stem cells derived from the placenta. The trial, and others including an effort to treat muscular dystrophy, highlight the potential power of stem cell therapy.

The first CRISPR-approved treatment was for sickle cell anemia in 2023

Victoria Gray was the first patient to receive a CRISPR-based therapy, which eliminated her symptoms and restored her health. The therapy's initial cost of $2.2M has kept it out of reach of many patients.

Before the first human spaceflight in 1961, scientists sent fruit flies, monkeys, and dogs into space.

A physician with a rare and deadly disease saved his own life by identifying an existing medication that he repurposed for his condition, and now he's using AI to try to do the same for other patients.

The US FDA issued a 2025 warning about BPC-157 and other popular peptides that are marketed for various regenerative properties.

Type 2 diabetes is a chronic disease that develops over time

Almost 90 to 95% of people with diabetes have Type 2 diabetes, occuring when the pancreas doesn't make enough insulin or the insulin fails to work correctly. Insulin malfunction causes the pancreas to crank out increasingly high amounts of the blood sugar-regulating hormone, leading to overwork and reductions in production.

Jonas Salk developed the first successful polio vaccine—and tested it on himself

The American medical researcher developed the inactivated virus vaccine from 1952 to 1955 and proved that it could prevent disease. He tested the virus on himself and his family in 1954 and then carried out formal clinical trials on more than 1.3 million children.

FDA approved the first ever peanut allergy treatment in January 2020

This new medication, called Palforzia, is designed to stave off severe reactions from accidental peanut exposures with a daily dose that is increased over time under an allergist’s supervision. It’s not a treatment that should be administered during an allergic reaction, however. Epinephrine, usually administered via injection, remains the intervention for severe reactions.

Gene therapy, a hope of the Human Genome Project, has successfully treated a baby born with a rare urea cycle disorder that causes toxic ammonia level buildup.